Clinical Research Directory
Browse clinical research sites, groups, and studies.
TxAccess and Dd-cfDNA for Improved Care of Patients With Delayed Graft Function
Sponsor: Duke University
Summary
This is a prospective multicenter nonrandomized pragmatic hybrid effectiveness-implementation study to test the effectiveness of TxAccess in improving time to renal recovery and immunologic outcomes in patients with delayed graft function (DGF) and to assess barriers and facilitators to implementation of TxAccess in the post-transplant care period. Research blood will be collected for donor-derived cell-free DNA testing, and patient questionnaires will be administered.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
450
Start Date
2026-09-15
Completion Date
2029-06-30
Last Updated
2026-09-17
Healthy Volunteers
No
Conditions
Interventions
TxAccess
Software platform facilitating communication between transplant centers, nephrology practices, and dialysis facilities.
Donor-Derived Cell-Free DNA (dd-cfDNA)
Blood testing to assess allograft injury and immunologic outcomes.